Empowered Funds
CGON icon

Empowered Funds’s CG Oncology CGON Stock Holding History

Empowered Funds’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$201K Buy
+2,840
New +$209K ﹤0.01% 2254

Other funds holding CGON

Decheng Capital
Decheng Capital Menlo Park, California $685M AUM 129.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Empowered Funds's CGON Position: Q3 2026 in Review

Empowered Funds opened a new position in CG Oncology (CGON) in Q3 2026: 2,840 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #2254 among its holdings.

165 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • Empowered Funds held 2,840 shares of CG Oncology worth $201K as of Q3 2026.
  • CG Oncology was a new Empowered Funds position in Q3 2026.
  • CG Oncology made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2254 holding.
  • 165 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.